BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

728 related articles for article (PubMed ID: 26731013)

  • 1. ENETS Consensus Guidelines Update for the Management of Distant Metastatic Disease of Intestinal, Pancreatic, Bronchial Neuroendocrine Neoplasms (NEN) and NEN of Unknown Primary Site.
    Pavel M; O'Toole D; Costa F; Capdevila J; Gross D; Kianmanesh R; Krenning E; Knigge U; Salazar R; Pape UF; Öberg K;
    Neuroendocrinology; 2016; 103(2):172-85. PubMed ID: 26731013
    [No Abstract]   [Full Text] [Related]  

  • 2. ENETS Consensus Guidelines for High-Grade Gastroenteropancreatic Neuroendocrine Tumors and Neuroendocrine Carcinomas.
    Garcia-Carbonero R; Sorbye H; Baudin E; Raymond E; Wiedenmann B; Niederle B; Sedlackova E; Toumpanakis C; Anlauf M; Cwikla JB; Caplin M; O'Toole D; Perren A;
    Neuroendocrinology; 2016; 103(2):186-94. PubMed ID: 26731334
    [No Abstract]   [Full Text] [Related]  

  • 3. ENETS Consensus Guidelines for the management of patients with liver and other distant metastases from neuroendocrine neoplasms of foregut, midgut, hindgut, and unknown primary.
    Pavel M; Baudin E; Couvelard A; Krenning E; Öberg K; Steinmüller T; Anlauf M; Wiedenmann B; Salazar R;
    Neuroendocrinology; 2012; 95(2):157-76. PubMed ID: 22262022
    [No Abstract]   [Full Text] [Related]  

  • 4. [Consensus and controversy of endoscopic diagnosis and treatment of gastroenteropancreatic neuroendocrine tumors].
    Chen H; Chen Y
    Zhonghua Wei Chang Wai Ke Za Zhi; 2017 Sep; 20(9):982-986. PubMed ID: 28900987
    [TBL] [Abstract][Full Text] [Related]  

  • 5. ENETS Consensus Guidelines for the Standards of Care in Neuroendocrine Tumors: pre- and perioperative therapy in patients with neuroendocrine tumors.
    Akerström G; Falconi M; Kianmanesh R; Ruszniewski P; Plöckinger U; ;
    Neuroendocrinology; 2009; 90(2):203-8. PubMed ID: 19713712
    [No Abstract]   [Full Text] [Related]  

  • 6. ENETS Consensus Guidelines Update for the Management of Patients with Functional Pancreatic Neuroendocrine Tumors and Non-Functional Pancreatic Neuroendocrine Tumors.
    Falconi M; Eriksson B; Kaltsas G; Bartsch DK; Capdevila J; Caplin M; Kos-Kudla B; Kwekkeboom D; Rindi G; Klöppel G; Reed N; Kianmanesh R; Jensen RT;
    Neuroendocrinology; 2016; 103(2):153-71. PubMed ID: 26742109
    [No Abstract]   [Full Text] [Related]  

  • 7. Occipital Headache as Initial Manifestation of a Pancreatic Neuroendocrine Tumor.
    Tsoukalas N; Triantafyllidis A; Tolia M; Galanopoulos M; Kostakis ID; Demiri S; Toumpanakis C; Koumakis G
    J Gastrointest Cancer; 2018 Dec; 49(4):501-503. PubMed ID: 28283989
    [No Abstract]   [Full Text] [Related]  

  • 8. Highlights in GEP-NETs From the 13th Annual ENETS Conference for the Diagnosis and Treatment of Neuroendocrine Tumor Disease: Commentary.
    Iyer R; Hatoum H
    Clin Adv Hematol Oncol; 2016 May; 14(5 Suppl 7):17-9. PubMed ID: 27168109
    [No Abstract]   [Full Text] [Related]  

  • 9. Role of Locoregional and Systemic Approaches for the Treatment of Patients with Metastatic Neuroendocrine Tumors.
    Grandhi MS; Lafaro KJ; Pawlik TM
    J Gastrointest Surg; 2015 Dec; 19(12):2273-82. PubMed ID: 26341823
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Intervention in gastro-enteropancreatic neuroendocrine tumours.
    Baudin E; Planchard D; Scoazec JY; Guigay J; Dromain C; Hadoux J; Debaere T; Elias D; Ducreux M
    Best Pract Res Clin Gastroenterol; 2012 Dec; 26(6):855-65. PubMed ID: 23582924
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Management of gastro-entero-pancreatic neuroendocrine tumours (GEP NET): an introduction.
    Van Hootegem P; Borbath I; Verslype C
    Acta Gastroenterol Belg; 2009; 72(1):27-8. PubMed ID: 19402367
    [No Abstract]   [Full Text] [Related]  

  • 12. [2017 ENETS consensus guidelines: update for the standard of care of pancreatic neuroendocrine tumors].
    Gao HL; Liu L; Wang WQ; Yu XJ
    Zhonghua Wai Ke Za Zhi; 2018 Nov; 56(11):809-812. PubMed ID: 30392299
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Extra-appendicular neuroendocrine tumors: A report from the TREP project (2000-2020).
    Virgone C; Ferrari A; Chiaravalli S; De Pasquale MD; Inserra A; D'Angelo P; Ogunleye MF; Crocoli A; Vallero S; Cesaro S; Alaggio R; Bisogno G; Dall'Igna P
    Pediatr Blood Cancer; 2021 Apr; 68(4):e28880. PubMed ID: 33522705
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Multidisciplinary approach for the treatment of neuroendocrine tumors.
    de Herder WW; Mazzaferro V; Tavecchio L; Wiedenmann B
    Tumori; 2010; 96(5):833-46. PubMed ID: 21302641
    [No Abstract]   [Full Text] [Related]  

  • 15. Current status of Interventional Radiology in the management of Gastro-Entero-Pancreatic Neuroendocrine Tumours (GEP-NETs).
    Orgera G; Krokidis M; Cappucci M; Gourtsoyianni S; Tipaldi MA; Hatzidakis A; Rebonato A; Rossi M
    Cardiovasc Intervent Radiol; 2015 Feb; 38(1):13-24. PubMed ID: 25366087
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Neuroendocrine Neoplasia within the German NET Registry].
    ; ;
    Z Gastroenterol; 2018 Oct; 56(10):1237-1246. PubMed ID: 30304748
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Neuroendocrine tumors: answers-and questions.
    Kulke M
    Oncology (Williston Park); 2014 Sep; 28(9):758, 760. PubMed ID: 25224472
    [No Abstract]   [Full Text] [Related]  

  • 18. The prognosis and management of neuroendocrine neoplasms-related metastatic bone disease: lessons from clinical practice.
    Alexandraki KI; Pizanias M; Uri I; Thomas D; Page T; Kolomodi D; Low CS; Adesanya O; Tsoli M; Gross DJ; Randeva H; Srirajaskanthan R; Grozinsky-Glasberg S; Kaltsas G; Weickert MO
    Endocrine; 2019 Jun; 64(3):690-701. PubMed ID: 30635793
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Gastrointestinal neuroendocrine tumors: slow but steady progress.
    Dasari A; Yao JC
    Oncology (Williston Park); 2014 Sep; 28(9):762-3. PubMed ID: 25224473
    [No Abstract]   [Full Text] [Related]  

  • 20. [The treatment of gastroenteropancreatic neuroendocrine tumors].
    Tóth M
    Magy Onkol; 2018 Jul; 62(2):99-106. PubMed ID: 30027937
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 37.